Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Mitogenic effects of coagulation factor XII and factor XIIa on HepG2 cells

Journal Article · · Proceedings of the National Academy of Sciences of the United States of America; (United States)
;  [1];  [2]
  1. Univ. of Southern California, Los Angeles (United States)
  2. Case Western Reserve Univ. School of Medicine, Cleveland, OH (United States)
The structure of coagulation factor XII (Hageman factor), inferred from its DNA sequence, includes two epidermal growth factor (EGF)-homologous domains in its amino-terminal region. This suggests that factor XII may exhibit EGF-like activities. Reciprocal antigenic cross-reactivity between factor XII and EGF was shown by exposing purified human factor XII or mouse EGF to anti-mouse EGF or anti-human factor XII. Western blot analysis showed that anti-mouse EGF recognized intact factor XII at 80 kDa. Together, these results suggest that the EGF-homologous domains are accessible for anti-EGF binding in native factor XII. To determine whether factor XII has mitogenic activity, HepG2 or L cells (10{sup 4} cells per well) were grown in serum-free medium in the presence or absence of factor XII or kaolin-activated factor XII (factor XIIa). Both factors XII and XIIa (6.0 {mu}g/ml) enhanced cell proliferation. Various doses of factor XII enhanced cell proliferation, ({sup 3}H)thymidine incorporation, and ({sup 3}H)leucine incorporation in HepG2 cells cultured under the same conditions. These data indicate that factor XII, like EGF, is a mitogen for HepG2 cells and suggest a possible autocrine role in the liver.
OSTI ID:
5933984
Journal Information:
Proceedings of the National Academy of Sciences of the United States of America; (United States), Journal Name: Proceedings of the National Academy of Sciences of the United States of America; (United States) Vol. 88:10; ISSN PNASA; ISSN 0027-8424
Country of Publication:
United States
Language:
English